Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ
Published December 11, 2019 · Recall initiated: November 12, 2019
Summary
FDA records drug Class II recall D-0609-2020, published December 11, 2019 and initiated November 12, 2019. Recalling firm: AuroMedics Pharma LLC; Status: Terminated; Reported quantity: 59,500 vials; Lot: Lot CFD190004, exp. date August 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Discoloration; Hazy solution found in one vial instead of a clear solution.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- AuroMedics Pharma LLC
- Distributor
- Product was distributed to major wholesalers/distributors who may have further distribute the product throughout the United States.
- Lot
- Lot CFD190004, exp. date August 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAFondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by:November 2, 2022
- FDAAcyclovir Sodium Injection, 500mg/10mL (50mg/mL), 10 mL Single Dose Vial, Rx only, Distributed by: AuroMedicsOctober 26, 2022
- FDATranexamic Acid Injection, USP, 1000mg per 10 mL (100mg /mL), 10mL single-dose vial, Rx Only, Distributed by:October 12, 2022
- FDAPolymyxin B for Injection USP, 500,000 Units per Vial, 10 mL vials, packaged in 10 vials per carton, Sterile,February 16, 2022
- FDAfentaNYL 550 mcg/55 mL (10 mcg/mL) in 0.9% Sodium Chloride 55 mL Syringe Preservative Free, Rx, QuVA PharmaDecember 11, 2019
- FDAEXPAREL, Bupivicaine Liposome Injectable Suspension, 1.3%, 266 mg/20 mL (13 mg/mL), Sterile, 20 mL vial, RxDecember 11, 2019
Questions about this recall
Was Fluphenazine Decanoate Injection USP 125mg/5mL, (5 mL Multiple Dose Vial), Rx only, For IM or SC Use, Mfd in India for: AuroMedics Pharma, LLC, E. Windsor, NJ recalled?
Yes. FDA published recall D-0609-2020 on December 11, 2019. Reported hazard: Discoloration; Hazy solution found in one vial instead of a clear solution.
What should I do if I have this product?
Voluntary: Firm initiated · Letter